Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ) Identifier:
First received: March 12, 2010
Last updated: March 18, 2015
Last verified: March 2015